We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
13 hedge funds and large institutions have $2.23M invested in Cyclo Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
17% less capital invested
Capital invested by funds: $2.7M → $2.23M (-$462K)
Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
1
Calls
$2.36M
Puts
–
Net Calls
+$2.36M
Net Calls Change
+$2.36M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$225K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$158K |
| 3 |
Two Sigma Advisers
New York
|
+$95.4K |
| 4 |
Renaissance Technologies
New York
|
+$82K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$69.4K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$118K |
| 2 |
Morgan Stanley
New York
|
-$7.04K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$1K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$8 |